Abstract
While proximal isovelocity surface area (PISA) method is one of the most common echocardiographic methods for quantitative mitral regurgitation (MR) assessment, accurate MR quantification remains challenging. This study examined the theoretical background of PISA, performed virtual echocardiography on computer models of functional MR, and quantified different sources of errors in PISA. For regurgitant flow rate measurement, the conventional 2D hemispherical PISA caused significant underestimation due to underestimation of PISA area, the multiplane 2D hemiellipsoidal and hemicylindrical PISA provided improved accuracy with better assumptions on PISA contour shape. With the direct capture of PISA area, the 3D-PISA was found to be the most accurate. However, it should be noted that PISA method is subject to systematic underestimation due to the Doppler angle effect, and systematic overestimation due to the “flow direction angle” between the regurgitant flow direction and the PISA contour normal direction. For regurgitant volume quantification, integrated PISA, when performed properly, was able to capture the dynamic MR and therefore was more accurate than peak PISA. In specific, integrated PISA using the sum of regurgitant flow rates is recommended.
Objectives The aim of this study was to evaluate the accuracy of different proximal isovelocity surface area (PISA) methods, examine their theoretical background, and quantify multiple sources of error in functional mitral regurgitation (MR) assessment.
Background While PISA method is one of the most common echocardiographic methods for MR severity assessment, it is associated with multiple sources of errors, and accurate MR quantification remains challenging.
Methods Five functional MR (FMR) computer models were created, validated and treated as phantom models. The phantom models have fully resolved and detailed flow fields in the left atrium (LA), left ventricle (LV) and cross the mitral valve, from which the reference values of mitral regurgitant flow rate and regurgitant volume can be obtained. The virtual PISA measurements (i.e., 3D and 2D PISA) were performed on the phantom models assuming optimal echo probe angulation and positioning. The results of different PISA methods were compared with the reference values.
Results For regurgitant flow rate measurements, compared to the reference values, excellent correlations were observed for 3D-PISA (R = 0.97, bias -24.4 ± 55.5 ml/s), followed by multiplane 2D hemicylindrical (HC)-PISA (R = 0.88, bias -24.1 ± 85.4 ml/s) and hemiellipsoidal (HE)-PISA (R = 0.91, bias -55.7 ± 96.6 ml/s), while weaker correlations were observed for single plane 2D hemispherical (HS)-PISA with large underestimation (PLAX view: R = 0.71, bias -77.6 ± 124.5 ml/s; A2Ch view: R = 0.69, bias -52.0 ± 122.0 ml/s; A4Ch view: R = 0.82, bias -65.5 ± 107.3 ml/s). For regurgitant volume (RV) quantification, integrated PISA presented improved accuracy over peak PISA for all PISA methods. For 3D-PISA, the bias in RV improved from -12.7 ± 7.8 ml (peak PISA) to -2.1 ± 5.3 ml (integrated PISA).
Conclusions In FMR, conventional single plane 2D HS-PISA significantly underestimated MR, multiplane 2D PISA (HE-PISA and HC-PISA) improved the accuracy, and 3D-PISA is the most accurate. To better capture the dynamic feature of MR, integrated PISA using the sum of regurgitant flow rates is recommended.
Competing Interest Statement
Dr. Wei Sun is a co-founder and serves as the Chief Scientific Advisor of Dura Biotech. He has received compensation and owns equity in the company. Dr. Rebecca Hahn is a speaker for Abbott Vascular, Boston Scientific, Edwards Lifesciences, Philips Healthcare, and on the advisory board/consultant for Edwards Lifesciences, Gore & Associates, Medtronic, and Navigate. The remaining authors have nothing to disclose.
Funding Statement
Dr. Tongran Qin was in part supported by the American Heart Association (AHA) Postdoctoral Fellowship 19POST34450161. Dr. Andres Caballero was in part supported by a Fulbright-Colciencias Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB-approved protocols were obtained from Georgia Tech Institutional Review Board and Columbia University Institutional Review Board.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data was included in the paper
ABBREVIATIONS AND ACRONYMS
- MR
- mitral regurgitation
- Echo
- echocardiography
- FMR
- functional mitral regurgitation
- PISA
- proximal isovelocity surface area
- EROA
- effective regurgitant orifice area
- RV
- regurgitant volume
- RF
- regurgitant fraction
- FSI
- fluid-structure interaction
- PM
- papillary muscle
- AV
- aortic valve
- MV
- mitral valve
- AML
- anterior mitral leaflet
- PML
- posterior mitral leaflet
- LV
- left ventricle
- LA
- left atrium
- SV
- stroke volume
- HE
- hemiellipsoidal
- HC
- hemicylindrical
- HS
- hemispherical
- PLAX
- parasternal long-axis
- A2ch
- apical 2-chamber
- A4ch
- apical 4-chamber
- CWD
- continuous wave Doppler
- VTI
- velocity time integral